Cargando…

6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach

The SH-SY5Y human neuroblastoma cells have been used for decades as a cell-based model of dopaminergic neurons to explore the underlying science of cellular and molecular mechanisms of neurodegeneration in Parkinson’s disease (PD). However, data revealing the protein expression changes in 6-OHDA ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Magalingam, Kasthuri Bai, Somanath, Sushela Devi, Ramdas, Premdass, Haleagrahara, Nagaraja, Radhakrishnan, Ammu Kutty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064865/
https://www.ncbi.nlm.nih.gov/pubmed/35258800
http://dx.doi.org/10.1007/s12031-021-01962-z
_version_ 1784699477075951616
author Magalingam, Kasthuri Bai
Somanath, Sushela Devi
Ramdas, Premdass
Haleagrahara, Nagaraja
Radhakrishnan, Ammu Kutty
author_facet Magalingam, Kasthuri Bai
Somanath, Sushela Devi
Ramdas, Premdass
Haleagrahara, Nagaraja
Radhakrishnan, Ammu Kutty
author_sort Magalingam, Kasthuri Bai
collection PubMed
description The SH-SY5Y human neuroblastoma cells have been used for decades as a cell-based model of dopaminergic neurons to explore the underlying science of cellular and molecular mechanisms of neurodegeneration in Parkinson’s disease (PD). However, data revealing the protein expression changes in 6-OHDA induced cytotoxicity in differentiated SH-SY5Y cells remain void. Therefore, we investigated the differentially regulated proteins expressed in terminally differentiated SH-SY5Y cells (differ-SH-SY5Y neural cells) exposed to 6-hydroxydopamine (6-OHDA) using the LC–MS/MS technology and construed the data using the online bioinformatics databases such as PANTHER, STRING, and KEGG. Our studies demonstrated that the neuronal development in differ-SH-SY5Y neural cells was indicated by the overexpression of proteins responsible for neurite formations such as calnexin (CANX) and calreticulin (CALR) besides significant downregulation of ribosomal proteins. The enrichment of the KEGG ribosome pathway was detected with significant downregulation (p < 0.05) of all the 21 ribosomal proteins in differ-SH-SY5Y neural cells compared with undifferentiated cells. Whereas in the PD model, the pathological changes induced by 6-OHDA were indicated by the presence of unfolded and misfolded proteins, which triggered the response of 10 kDa heat shock proteins (HSP), namely HSPE1 and HSPA9. Moreover, the 6-OHDA-induced neurodegeneration in differ-SH-SY5Y neural cells also upregulated the voltage-dependent anion-selective channel protein 1 (VDAC1) protein and enriched the KEGG systemic lupus erythematosus (SLE) pathway that was regulated by 17 histone proteins (p < 0.05) in differ-SH-SY5Y neural cells. These results suggest that the nucleosomal degradation pathway may have regulated the 6-OHDA induced neurodegeneration in PD cell-based model, which is reflected by increased apoptosis and histone release in differ-SH-SY5Y neural cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12031-021-01962-z.
format Online
Article
Text
id pubmed-9064865
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-90648652022-05-07 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach Magalingam, Kasthuri Bai Somanath, Sushela Devi Ramdas, Premdass Haleagrahara, Nagaraja Radhakrishnan, Ammu Kutty J Mol Neurosci Article The SH-SY5Y human neuroblastoma cells have been used for decades as a cell-based model of dopaminergic neurons to explore the underlying science of cellular and molecular mechanisms of neurodegeneration in Parkinson’s disease (PD). However, data revealing the protein expression changes in 6-OHDA induced cytotoxicity in differentiated SH-SY5Y cells remain void. Therefore, we investigated the differentially regulated proteins expressed in terminally differentiated SH-SY5Y cells (differ-SH-SY5Y neural cells) exposed to 6-hydroxydopamine (6-OHDA) using the LC–MS/MS technology and construed the data using the online bioinformatics databases such as PANTHER, STRING, and KEGG. Our studies demonstrated that the neuronal development in differ-SH-SY5Y neural cells was indicated by the overexpression of proteins responsible for neurite formations such as calnexin (CANX) and calreticulin (CALR) besides significant downregulation of ribosomal proteins. The enrichment of the KEGG ribosome pathway was detected with significant downregulation (p < 0.05) of all the 21 ribosomal proteins in differ-SH-SY5Y neural cells compared with undifferentiated cells. Whereas in the PD model, the pathological changes induced by 6-OHDA were indicated by the presence of unfolded and misfolded proteins, which triggered the response of 10 kDa heat shock proteins (HSP), namely HSPE1 and HSPA9. Moreover, the 6-OHDA-induced neurodegeneration in differ-SH-SY5Y neural cells also upregulated the voltage-dependent anion-selective channel protein 1 (VDAC1) protein and enriched the KEGG systemic lupus erythematosus (SLE) pathway that was regulated by 17 histone proteins (p < 0.05) in differ-SH-SY5Y neural cells. These results suggest that the nucleosomal degradation pathway may have regulated the 6-OHDA induced neurodegeneration in PD cell-based model, which is reflected by increased apoptosis and histone release in differ-SH-SY5Y neural cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12031-021-01962-z. Springer US 2022-03-08 2022 /pmc/articles/PMC9064865/ /pubmed/35258800 http://dx.doi.org/10.1007/s12031-021-01962-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Magalingam, Kasthuri Bai
Somanath, Sushela Devi
Ramdas, Premdass
Haleagrahara, Nagaraja
Radhakrishnan, Ammu Kutty
6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach
title 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach
title_full 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach
title_fullStr 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach
title_full_unstemmed 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach
title_short 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach
title_sort 6-hydroxydopamine induces neurodegeneration in terminally differentiated sh-sy5y neuroblastoma cells via enrichment of the nucleosomal degradation pathway: a global proteomics approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064865/
https://www.ncbi.nlm.nih.gov/pubmed/35258800
http://dx.doi.org/10.1007/s12031-021-01962-z
work_keys_str_mv AT magalingamkasthuribai 6hydroxydopamineinducesneurodegenerationinterminallydifferentiatedshsy5yneuroblastomacellsviaenrichmentofthenucleosomaldegradationpathwayaglobalproteomicsapproach
AT somanathsusheladevi 6hydroxydopamineinducesneurodegenerationinterminallydifferentiatedshsy5yneuroblastomacellsviaenrichmentofthenucleosomaldegradationpathwayaglobalproteomicsapproach
AT ramdaspremdass 6hydroxydopamineinducesneurodegenerationinterminallydifferentiatedshsy5yneuroblastomacellsviaenrichmentofthenucleosomaldegradationpathwayaglobalproteomicsapproach
AT haleagraharanagaraja 6hydroxydopamineinducesneurodegenerationinterminallydifferentiatedshsy5yneuroblastomacellsviaenrichmentofthenucleosomaldegradationpathwayaglobalproteomicsapproach
AT radhakrishnanammukutty 6hydroxydopamineinducesneurodegenerationinterminallydifferentiatedshsy5yneuroblastomacellsviaenrichmentofthenucleosomaldegradationpathwayaglobalproteomicsapproach